Plasma concentration of cytokine antagonists in patients with HIV infection

Anna Catania, Maria G. Manfredi, Lorena Airaghi, Maria C. Vivirito, Amedeo Capetti, Francesco Milazzo, James M. Lipton, Carlo Zanussi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

There is increasing evidence that cytokines contribute to the immunopathogen- esis of human immunodeficiency vims (HIV) infection. It may be, therefore, that compensatory rises in circulating cytokine antagonists also occur in HIV infection and that such changes mark disease progression. To test this idea, plasma concentrations of the cytokine antagonists a-melanocyte-stimulating hormone (α-MSH), interleukin-1 receptor antagonist (IL-lra), and soluble tumor necrosis factor receptor (sTNFr) were measured in patients of different Centers for Disease Control (CDC) categories of HIV infection and in serone-gative controls. Plasma levels of all these cytokine antagonists were higher in HIV-infected patients. IL-lra and sTNFr concentrations were correlated with indicators of disease activity: positively with plasma neopterin and negatively with CD4+ T lymphocyte counts. α-MSH and sTNF r were greater in CDC groups III and IV, whereras IL-lra was elevated only in the latter group. Because cytokines activate the hypothalamic-pituitary-adrenal axis and adrenal steroids inhibit cytokine production, we measured circulating adrenocorti-cotropic hormone (ACTH) and cortisol in HIV-infected patients and investi-gated relations among these hormones, cytokine antagonists, and markers of disease progression. It appears that these physiological modulators of cytokine activity are not closely linked to sTNFr, IL-lra and α-MSH: there were no significant correlations between plasma concentrations of ACTH or cortisol and those of cytokine antagonists, nor were there correlations between hor-mones and markers of disease progression such as neopterin or CD4+ T cell counts. It is notable that severe adrenal insufficiency was extremely rare (3%) in HIV-infected patients; it was confined to the AIDS group and was consis-tently secondary to ACTH deficiency. Finally, because of the recent expansion of the AIDS case definition to include all patients with CD4+ T cell counts less than 200/μl, we examined cytokine antagonists, hormones and neopterin in a subset of patients included in the AIDS group because oflow CD4+ T cells in the absence of clinical criteria formerly required for AIDS case definition. Cytokine antagonists and neopterin concentrations in patients with low CD4+ T cells were similar to those of patients with the clinical complications of AIDS. The results indicate that: (1) plasma concentrations of cytokine antagonists are increased in HIV infection particularly in later stages of the disease, and (2) the recent expansion of the AIDS case definition to one including a low CD4+ T cell count results in the inclusion of patients who have disease markers similar to those of patients who meet the clinical criteria for AIDS.

Original languageEnglish
Pages (from-to)42-49
Number of pages8
JournalNeuroImmunoModulation
Volume1
Issue number1
DOIs
Publication statusPublished - 1994

Fingerprint

Cytokines
Infection
Acquired Immunodeficiency Syndrome
Neopterin
CD4 Lymphocyte Count
Melanocyte-Stimulating Hormones
T-Lymphocytes
Tumor Necrosis Factor Receptors
Hormone Antagonists
Disease Progression
Hormones
Centers for Disease Control and Prevention (U.S.)
Hydrocortisone
Adrenal Insufficiency
Interleukin-1 Receptors
Steroids
Control Groups

Keywords

  • AIDS
  • HIV infection
  • Interleukin-1 receptor antagonist
  • Soluble tumor necrosis factor receptor
  • α-Melanocyte-stimulating hormone

ASJC Scopus subject areas

  • Endocrinology
  • Immunology
  • Endocrine and Autonomic Systems
  • Neurology
  • Neuroscience(all)

Cite this

Catania, A., Manfredi, M. G., Airaghi, L., Vivirito, M. C., Capetti, A., Milazzo, F., ... Zanussi, C. (1994). Plasma concentration of cytokine antagonists in patients with HIV infection. NeuroImmunoModulation, 1(1), 42-49. https://doi.org/10.1159/000097089

Plasma concentration of cytokine antagonists in patients with HIV infection. / Catania, Anna; Manfredi, Maria G.; Airaghi, Lorena; Vivirito, Maria C.; Capetti, Amedeo; Milazzo, Francesco; Lipton, James M.; Zanussi, Carlo.

In: NeuroImmunoModulation, Vol. 1, No. 1, 1994, p. 42-49.

Research output: Contribution to journalArticle

Catania, A, Manfredi, MG, Airaghi, L, Vivirito, MC, Capetti, A, Milazzo, F, Lipton, JM & Zanussi, C 1994, 'Plasma concentration of cytokine antagonists in patients with HIV infection', NeuroImmunoModulation, vol. 1, no. 1, pp. 42-49. https://doi.org/10.1159/000097089
Catania, Anna ; Manfredi, Maria G. ; Airaghi, Lorena ; Vivirito, Maria C. ; Capetti, Amedeo ; Milazzo, Francesco ; Lipton, James M. ; Zanussi, Carlo. / Plasma concentration of cytokine antagonists in patients with HIV infection. In: NeuroImmunoModulation. 1994 ; Vol. 1, No. 1. pp. 42-49.
@article{59003528180f4333acd6c8ee72fb25de,
title = "Plasma concentration of cytokine antagonists in patients with HIV infection",
abstract = "There is increasing evidence that cytokines contribute to the immunopathogen- esis of human immunodeficiency vims (HIV) infection. It may be, therefore, that compensatory rises in circulating cytokine antagonists also occur in HIV infection and that such changes mark disease progression. To test this idea, plasma concentrations of the cytokine antagonists a-melanocyte-stimulating hormone (α-MSH), interleukin-1 receptor antagonist (IL-lra), and soluble tumor necrosis factor receptor (sTNFr) were measured in patients of different Centers for Disease Control (CDC) categories of HIV infection and in serone-gative controls. Plasma levels of all these cytokine antagonists were higher in HIV-infected patients. IL-lra and sTNFr concentrations were correlated with indicators of disease activity: positively with plasma neopterin and negatively with CD4+ T lymphocyte counts. α-MSH and sTNF r were greater in CDC groups III and IV, whereras IL-lra was elevated only in the latter group. Because cytokines activate the hypothalamic-pituitary-adrenal axis and adrenal steroids inhibit cytokine production, we measured circulating adrenocorti-cotropic hormone (ACTH) and cortisol in HIV-infected patients and investi-gated relations among these hormones, cytokine antagonists, and markers of disease progression. It appears that these physiological modulators of cytokine activity are not closely linked to sTNFr, IL-lra and α-MSH: there were no significant correlations between plasma concentrations of ACTH or cortisol and those of cytokine antagonists, nor were there correlations between hor-mones and markers of disease progression such as neopterin or CD4+ T cell counts. It is notable that severe adrenal insufficiency was extremely rare (3{\%}) in HIV-infected patients; it was confined to the AIDS group and was consis-tently secondary to ACTH deficiency. Finally, because of the recent expansion of the AIDS case definition to include all patients with CD4+ T cell counts less than 200/μl, we examined cytokine antagonists, hormones and neopterin in a subset of patients included in the AIDS group because oflow CD4+ T cells in the absence of clinical criteria formerly required for AIDS case definition. Cytokine antagonists and neopterin concentrations in patients with low CD4+ T cells were similar to those of patients with the clinical complications of AIDS. The results indicate that: (1) plasma concentrations of cytokine antagonists are increased in HIV infection particularly in later stages of the disease, and (2) the recent expansion of the AIDS case definition to one including a low CD4+ T cell count results in the inclusion of patients who have disease markers similar to those of patients who meet the clinical criteria for AIDS.",
keywords = "AIDS, HIV infection, Interleukin-1 receptor antagonist, Soluble tumor necrosis factor receptor, α-Melanocyte-stimulating hormone",
author = "Anna Catania and Manfredi, {Maria G.} and Lorena Airaghi and Vivirito, {Maria C.} and Amedeo Capetti and Francesco Milazzo and Lipton, {James M.} and Carlo Zanussi",
year = "1994",
doi = "10.1159/000097089",
language = "English",
volume = "1",
pages = "42--49",
journal = "NeuroImmunoModulation",
issn = "1021-7401",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Plasma concentration of cytokine antagonists in patients with HIV infection

AU - Catania, Anna

AU - Manfredi, Maria G.

AU - Airaghi, Lorena

AU - Vivirito, Maria C.

AU - Capetti, Amedeo

AU - Milazzo, Francesco

AU - Lipton, James M.

AU - Zanussi, Carlo

PY - 1994

Y1 - 1994

N2 - There is increasing evidence that cytokines contribute to the immunopathogen- esis of human immunodeficiency vims (HIV) infection. It may be, therefore, that compensatory rises in circulating cytokine antagonists also occur in HIV infection and that such changes mark disease progression. To test this idea, plasma concentrations of the cytokine antagonists a-melanocyte-stimulating hormone (α-MSH), interleukin-1 receptor antagonist (IL-lra), and soluble tumor necrosis factor receptor (sTNFr) were measured in patients of different Centers for Disease Control (CDC) categories of HIV infection and in serone-gative controls. Plasma levels of all these cytokine antagonists were higher in HIV-infected patients. IL-lra and sTNFr concentrations were correlated with indicators of disease activity: positively with plasma neopterin and negatively with CD4+ T lymphocyte counts. α-MSH and sTNF r were greater in CDC groups III and IV, whereras IL-lra was elevated only in the latter group. Because cytokines activate the hypothalamic-pituitary-adrenal axis and adrenal steroids inhibit cytokine production, we measured circulating adrenocorti-cotropic hormone (ACTH) and cortisol in HIV-infected patients and investi-gated relations among these hormones, cytokine antagonists, and markers of disease progression. It appears that these physiological modulators of cytokine activity are not closely linked to sTNFr, IL-lra and α-MSH: there were no significant correlations between plasma concentrations of ACTH or cortisol and those of cytokine antagonists, nor were there correlations between hor-mones and markers of disease progression such as neopterin or CD4+ T cell counts. It is notable that severe adrenal insufficiency was extremely rare (3%) in HIV-infected patients; it was confined to the AIDS group and was consis-tently secondary to ACTH deficiency. Finally, because of the recent expansion of the AIDS case definition to include all patients with CD4+ T cell counts less than 200/μl, we examined cytokine antagonists, hormones and neopterin in a subset of patients included in the AIDS group because oflow CD4+ T cells in the absence of clinical criteria formerly required for AIDS case definition. Cytokine antagonists and neopterin concentrations in patients with low CD4+ T cells were similar to those of patients with the clinical complications of AIDS. The results indicate that: (1) plasma concentrations of cytokine antagonists are increased in HIV infection particularly in later stages of the disease, and (2) the recent expansion of the AIDS case definition to one including a low CD4+ T cell count results in the inclusion of patients who have disease markers similar to those of patients who meet the clinical criteria for AIDS.

AB - There is increasing evidence that cytokines contribute to the immunopathogen- esis of human immunodeficiency vims (HIV) infection. It may be, therefore, that compensatory rises in circulating cytokine antagonists also occur in HIV infection and that such changes mark disease progression. To test this idea, plasma concentrations of the cytokine antagonists a-melanocyte-stimulating hormone (α-MSH), interleukin-1 receptor antagonist (IL-lra), and soluble tumor necrosis factor receptor (sTNFr) were measured in patients of different Centers for Disease Control (CDC) categories of HIV infection and in serone-gative controls. Plasma levels of all these cytokine antagonists were higher in HIV-infected patients. IL-lra and sTNFr concentrations were correlated with indicators of disease activity: positively with plasma neopterin and negatively with CD4+ T lymphocyte counts. α-MSH and sTNF r were greater in CDC groups III and IV, whereras IL-lra was elevated only in the latter group. Because cytokines activate the hypothalamic-pituitary-adrenal axis and adrenal steroids inhibit cytokine production, we measured circulating adrenocorti-cotropic hormone (ACTH) and cortisol in HIV-infected patients and investi-gated relations among these hormones, cytokine antagonists, and markers of disease progression. It appears that these physiological modulators of cytokine activity are not closely linked to sTNFr, IL-lra and α-MSH: there were no significant correlations between plasma concentrations of ACTH or cortisol and those of cytokine antagonists, nor were there correlations between hor-mones and markers of disease progression such as neopterin or CD4+ T cell counts. It is notable that severe adrenal insufficiency was extremely rare (3%) in HIV-infected patients; it was confined to the AIDS group and was consis-tently secondary to ACTH deficiency. Finally, because of the recent expansion of the AIDS case definition to include all patients with CD4+ T cell counts less than 200/μl, we examined cytokine antagonists, hormones and neopterin in a subset of patients included in the AIDS group because oflow CD4+ T cells in the absence of clinical criteria formerly required for AIDS case definition. Cytokine antagonists and neopterin concentrations in patients with low CD4+ T cells were similar to those of patients with the clinical complications of AIDS. The results indicate that: (1) plasma concentrations of cytokine antagonists are increased in HIV infection particularly in later stages of the disease, and (2) the recent expansion of the AIDS case definition to one including a low CD4+ T cell count results in the inclusion of patients who have disease markers similar to those of patients who meet the clinical criteria for AIDS.

KW - AIDS

KW - HIV infection

KW - Interleukin-1 receptor antagonist

KW - Soluble tumor necrosis factor receptor

KW - α-Melanocyte-stimulating hormone

UR - http://www.scopus.com/inward/record.url?scp=0028366799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028366799&partnerID=8YFLogxK

U2 - 10.1159/000097089

DO - 10.1159/000097089

M3 - Article

C2 - 8528884

AN - SCOPUS:0028366799

VL - 1

SP - 42

EP - 49

JO - NeuroImmunoModulation

JF - NeuroImmunoModulation

SN - 1021-7401

IS - 1

ER -